ADARX PHARMACEUTICALS Trademark
Trademark Overview
On Friday, July 11, 2025, a trademark application was filed for ADARX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ADARX PHARMACEUTICALS trademark a serial number of 99279029. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 2, 2026. This trademark is owned by ADARX PHARMACEUTICALS, INC.. The ADARX PHARMACEUTICALS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
(Based on Intent To Use) Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer
(Based on Intent To Use) Nucleotides for scientific and research use; nucleotides for use in the manufacture of pharmaceuticals
(Based on Use in Commerce) Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development
General Information
| Serial Number | 99279029 |
| Word Mark | ADARX PHARMACEUTICALS |
| Filing Date | Friday, July 11, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 2, 2026 |
Trademark Statements
| Goods and Services | (Based on Intent To Use) Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer |
| Goods and Services | (Based on Intent To Use) Nucleotides for scientific and research use; nucleotides for use in the manufacture of pharmaceuticals |
| Goods and Services | (Based on Use in Commerce) Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development |
| NOT AVAILABLE | "PHARMACEUTICALS" |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, May 14, 2025 |
| First Use In Commerce Date | Wednesday, May 14, 2025 |
Trademark Owner History
| Party Name | ADARX PHARMACEUTICALS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
| Party Name | ADARX PHARMACEUTICALS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Friday, July 11, 2025 | NEW APPLICATION ENTERED |
| Friday, July 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, August 18, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 18, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, August 18, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 3, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 3, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, October 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 3, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, November 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 1, 2025 | ASSIGNED TO EXAMINER |
| Saturday, December 6, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, December 6, 2025 | NON-FINAL ACTION E-MAILED |
| Saturday, December 6, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 6, 2026 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Wednesday, March 4, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 4, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 4, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, March 7, 2026 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| Saturday, April 18, 2026 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Tuesday, May 5, 2026 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| Tuesday, May 5, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 27, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 2, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 2, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, June 3, 2026 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
